Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (35 ops.)
Latest filing published 05 Mar 2013 for BIOMIMETIC THERAPEUTICS, INC., €83k.
Insider track record
Disclosed buys
9
Disclosed sells
35
Signal history
No signal scores available.
Closed purchases
Market purchases
9
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Charles Federico: trading record in brief
Charles Federico discloses dealings in 5 companies, chiefly Orthofix Medical Inc., Biomimetic Therapeutics, Inc. and Power Medical Interventions, Inc. In total, 59 filings cover trades dated from 3 March 2006 to 17 December 2013.
Market trades split into 9 purchases (€120k) and 35 sales (€9.4M). Sales outweigh purchases by €9.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant and 11 option exercises.
A typical purchase (the median) is worth €3,641.
The record was last updated on 17 December 2013 with a transaction (€262k) in MAKO Surgical Corp. The most recent open-market purchase was published on 6 August 2012, 5,192 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles Federico
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations55 total
18,736 shares@ US$5.80Common StockSEC:0001209191-13-014352:0
11,977 shares@ US$9.07Common StockSEC:0001209191-13-014352:1
20,000 shares@ US$2.63Common StockSEC:0001209191-13-014352:2
27,834 sharesCommon StockSEC:0001209191-13-014352:3
2,000 shares@ US$12.95Common StockSEC:0001209191-12-040586:0
Canonical exit: 1 Nov 2012 (T+90)
5,000 shares@ US$3.70Common StockSEC:0001181431-12-040739:0
5,000 shares@ US$4.07Common StockSEC:0001181431-10-028142:0
Canonical exit: 11 Aug 2010 (T+90)
1,400 shares@ US$3.85Common StockSEC:0001104659-08-058260:0
Canonical exit: 16 Nov 2008 (T+90)
100 shares@ US$3.86Common StockSEC:0001104659-08-058260:1
Canonical exit: 16 Nov 2008 (T+90)
137 shares@ US$3.78Common StockSEC:0001104659-08-058260:2
Canonical exit: 16 Nov 2008 (T+90)
1,363 shares@ US$3.80Common StockSEC:0001104659-08-058260:3
Canonical exit: 16 Nov 2008 (T+90)
1,000 shares@ US$9.25Common StockSEC:0001209191-08-020971:0
Canonical exit: 26 Jun 2008 (T+90)
75 shares@ US$9.24Common StockSEC:0001209191-08-020971:1
Canonical exit: 26 Jun 2008 (T+90)
100 shares@ US$45.09Common StockSEC:0001213215-06-000005:10
8,800 shares@ US$37.76Common StockSEC:0001213215-06-000005:0
4,992 shares@ US$45.00Common StockSEC:0001213215-06-000005:1
598 shares@ US$45.01Common StockSEC:0001213215-06-000005:2
300 shares@ US$45.03Common StockSEC:0001213215-06-000005:3
1,294 shares@ US$45.04Common StockSEC:0001213215-06-000005:4
1,616 shares@ US$45.05Common StockSEC:0001213215-06-000005:5
35,000 shares@ US$43.04Common StockSEC:0001213215-06-000005:6
10,465 shares@ US$45.05Common StockSEC:0001213215-06-000005:7
106 shares@ US$45.06Common StockSEC:0001213215-06-000005:8
400 shares@ US$45.08Common StockSEC:0001213215-06-000005:9
17,230 shares@ US$45.10Common StockSEC:0001213215-06-000005:11
25 of 55 declarations
